Search
Chemomab Therapeutics Ltd
CMMBAdd to Watchlist
2.270USD
+0.550+31.98%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
65.38MMarket Cap
13.03P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+31.98%
5 Days
+42.77%
1 Month
+26.11%
6 Months
+26.82%
Year to Date
+37.58%
1 Year
-51.08%
Key Figures
1.750Open
2.420High
1.39MVolume
13.03P/E TTM
LossP/E Dynamic
--Dividend TTM
4.84%Turnover Ratio
1.700Prev. Close
1.750Low
2.08MTurnover
LossP/E Static
6.11P/B
0.00%Div Yield TTM
-60.46%ROA
5.56052wk High
7.60Volume Ratio
-13.95MNet Profit
28.80MShares
0.1742EPS TTM
0.61Beta
-70.61%ROE
1.35052wk Low
39.41%Amplitude
--Gross Margin
65.38MMarket Cap
-1.09Reward/Risk
5.11%Risk Rate
TradingKey Stock Score
No stock score available due to insufficient data.
Chemomab Therapeutics Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Chemomab Therapeutics Ltd Info
Chemomab Therapeutics Ltd (formerly known as Anchiano Therapeutics Ltd) is a Israel-based clinical-stage biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of fibrotic and inflammatory diseases with high unmet medical need among others. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.
Ticker SymbolCMMB
CompanyChemomab Therapeutics Ltd
CEOMor (Adi)
Websitehttps://www.chemomab.com/
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Chemomab Therapeutics Ltd (CMMB)?
The current price of Chemomab Therapeutics Ltd (CMMB) is 2.27.
What is the symbol of Chemomab Therapeutics Ltd?
The ticker symbol of Chemomab Therapeutics Ltd is CMMB.
What is the 52-week high of Chemomab Therapeutics Ltd?
The 52-week high of Chemomab Therapeutics Ltd is 5.56.
What is the 52-week low of Chemomab Therapeutics Ltd?
The 52-week low of Chemomab Therapeutics Ltd is 1.35.
What is the market capitalization of Chemomab Therapeutics Ltd?
The market capitalization of Chemomab Therapeutics Ltd is 65.38M.
Is Chemomab Therapeutics Ltd (CMMB) currently rated as Buy, Hold, or Sell?
According to analysts, Chemomab Therapeutics Ltd (CMMB) has an overall rating of STRONG BUY, with a price target of 15.00.
What is the Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB)?
The Earnings Per Share (EPS TTM) of Chemomab Therapeutics Ltd (CMMB) is -1.41.